Step therapy is a health insurance policy that requires you to try a less expensive medication before your plan will cover the one your doctor originally prescribed. Sometimes called “fail first,” it means you must show that a cheaper alternative didn’t work for you before your insurer approves the pricier drug. It’s one of the most common ways insurance companies manage prescription costs, and it affects millions of people with chronic conditions every year.
How Step Therapy Works
The basic idea is simple: your doctor prescribes a medication, but your insurance plan won’t cover it right away. Instead, the plan requires you to start with a lower-cost option, often a generic drug, a biosimilar, or a less expensive brand-name medication on the plan’s formulary. If that first-line drug doesn’t treat your condition effectively, or if you experience side effects, you can then “step up” to the medication your doctor originally recommended.
In practice, step therapy operates as a form of prior authorization. Your doctor submits the prescription, the insurer flags it, and you’re directed to try the cheaper alternative first. Only after documenting that the lower-cost drug failed, either because it didn’t help or caused problems, does the plan consider covering the originally prescribed medication. The number of steps varies. Some protocols require only one alternative, while others involve two or three drugs before you reach the one your doctor wanted you on in the first place.
Why Insurers Use It
Insurance companies frame step therapy as both a cost-saving measure and a clinical safeguard. The logic is that if a well-established generic medication works for most people with a given condition, there’s no reason to default to an expensive specialty drug. Many first-line treatments are genuinely effective, and starting with them can save both the insurer and the patient money.
The financial incentive is significant. Specialty medications for conditions like rheumatoid arthritis or psoriasis can cost tens of thousands of dollars a year, while generics or older brand-name alternatives may cost a fraction of that. Insurers argue that step therapy steers patients toward proven, cost-effective treatments first, reserving expensive options for those who truly need them.
Conditions Where Step Therapy Is Most Common
Step therapy isn’t applied evenly across all prescriptions. It’s concentrated in chronic, complex conditions where expensive specialty drugs are available. A study published in Health Affairs found that the ten conditions most frequently subject to step therapy protocols were chronic migraine, Crohn’s disease, psoriasis, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, polyarticular juvenile idiopathic arthritis, multiple sclerosis, and hepatitis C. Across those ten conditions, insurers applied step therapy in roughly 77 percent of their coverage policies.
These are conditions where newer biologic drugs have transformed treatment but come with high price tags. If you have psoriasis, for example, your dermatologist might want to prescribe a biologic, but your insurer could require you to try older topical treatments or oral medications first.
How It Affects Patients
For some people, step therapy is a minor inconvenience. The first-line drug works, costs less, and nothing is lost. But for others, the process creates real harm. Research from the American Journal of Managed Care paints a striking picture: 40 percent of patients stopped taking medications they were forced to step through because the drugs simply didn’t help. Another 29 percent stopped due to cost, and 27 percent stopped because their insurer ultimately didn’t pay for the medication at all.
The timeline is a major problem. Claims data show that patients who were eventually approved for their originally prescribed medication waited an average of 30 days to get it. But most patients gave up before that, stopping their efforts between 17 and 23 days into the process. That gap represents weeks without effective treatment for conditions that may be painful, progressive, or debilitating.
The downstream effects are broad. In surveys, 52 percent of patients said step therapy negatively affected their emotional health, 36 percent reported a decline in quality of life, and 20 percent said their overall health got worse. Among healthcare providers, 89 percent of physicians and 78 percent of pharmacists believed step therapy prevented patients from receiving the most effective available treatments.
How to Request an Exception
You are not required to accept a step therapy decision without pushback. Both you and your doctor can request an exception, asking the plan to skip the required steps and cover the prescribed drug directly. To do this, your doctor typically needs to submit a supporting statement explaining why the lower-cost drug is inappropriate for your situation. Valid reasons include medical necessity based on your specific condition, the likelihood of adverse effects from the cheaper drug, or evidence that the alternative would be less effective for you.
For Medicare Advantage plans, exception requests are generally processed within 72 hours when the situation is urgent. If your plan denies the request, you have the right to appeal, and the plan must provide a written notice explaining the denial along with instructions for the appeals process. CMS monitors these appeals to make sure plans are evaluating them appropriately.
If you’re switching insurance plans and are already on a medication that falls under step therapy, you may be eligible for a transition fill: a one-time, 30-day supply of your current drug to prevent a gap in treatment while you navigate the new plan’s requirements.
Tips for Navigating the Process
- Ask your doctor to document everything. If you’ve already tried and failed a lower-cost drug in the past, even years ago or under a different insurance plan, that history can sometimes satisfy the step therapy requirement without starting over.
- Request the exception early. Don’t wait until you’ve run out of your current medication. As soon as you learn step therapy applies, have your doctor submit the exception request.
- Keep records of side effects. If you’re required to try an alternative drug, track how it affects you in specific terms: what symptoms appeared, when they started, and how they compared to your previous treatment.
- Know your state’s protections. Many states have passed step therapy reform laws that limit how long insurers can require you to stay on an alternative drug, mandate clear timelines for exception decisions, or exempt certain conditions from step therapy entirely.
- Use the appeals process. A denial of your exception request is not the final word. Formal appeals are reviewed independently, and a meaningful percentage of denials are overturned on appeal.